CNS metastases
Information
- Disease name
- CNS metastases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04109131 | Recruiting | N/A | A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours | July 1, 2020 | January 2028 |
| NCT06322342 | Recruiting | Phase 2 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | March 15, 2024 | March 2025 |
| NCT06352502 | Recruiting | An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis | January 28, 2022 | September 30, 2024 | |
| NCT01322100 | Terminated | Phase 1 | Electrochemotherapy as a Palliative Treatment for Brain Metastases | April 2011 | July 2013 |
| NCT03275402 | Terminated | Phase 2/Phase 3 | 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases | December 11, 2018 | June 2, 2023 |
| NCT01312506 | Withdrawn | Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls | July 2012 | November 2012 |